Genetic analyses of the chimeric CYP11B1/CYP11B2 gene in a Korean family with glucocorticoid-remediable aldosteronism.
Glucocorticoid-remediable aldosteronism (GRA) is an autosomal-dominant inheritable form of hyperaldosteronism with early onset hypertension. GRA is caused by unequal crossing-over of the steroid 11 beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) genes. As a result of chimeric gene duplication, aldosterone is ectopically synthesized in the adrenal zona fasciculata under the control of adrenocorticotropin. Here, we describe three cases of GRA in a Korean family. The proband-a 21-yr-old female-was incidentally found to have high blood pressure (170/108 mmHg). Her 46-yr-old father had been treated twice for cerebral hemorrhage at the ages of 29 and 39 yr. Her 15-yr-old brother had a 2-yr history of hypertension; however, he was never treated. Their laboratory test results showed normokalemia, hyporeninemia, hyperaldosteronism, and a high plasma aldosterone concentration-to-plasma renin activity ratio. Normal saline loading failed to suppress aldosterone secretion. However, dexamethasone administration effectively suppressed their plasma aldosterone concentrations. Following genetic analyses with PCR and direct sequencing to document the chimeric gene and crossover site, respectively, we identified CYP11B1/CYP11B2 and determined the breakpoint of unequal crossover to be located between intron 2 of CYP11B1 and exon 3 of CYP11B2.
Lee
Ihn Suk
IS
Division of Endocrinology, Department of Internal Medicine, Incheon Medical Center, Incheon, Korea.
Kim
Seul Young
SY
Jang
Hye Won
HW
Kim
Min Kyeong
MK
Lee
Ju Hee
JH
Lee
Yun Hyeong
YH
Jo
Young Suk
YS
D000293:Adolescent; D000450:Aldosterone / Q000097:blood; D044466:Asian People / Q000235:genetics*; D019405:Cytochrome P-450 CYP11B2 / Q000235:genetics*; D003907:Dexamethasone / Q000627:therapeutic use; D005190:Family; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D006929:Hyperaldosteronism / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D006973:Hypertension / Q000209:etiology; D018810:Magnetic Resonance Angiography; D008297:Male; D008875:Middle Aged; D012083:Renin / Q000097:blood / Q000378:metabolism; D056910:Republic of Korea; D017422:Sequence Analysis, DNA; D013252:Steroid 11-beta-Hydroxylase / Q000235:genetics*; D055815:Young Adult
D005938:Glucocorticoids; D000450:Aldosterone; D003907:Dexamethasone; D019405:Cytochrome P-450 CYP11B2; D013252:Steroid 11-beta-Hydroxylase; D012083:Renin
J Clin Endocrinol Metab. 2000 Aug;85(8):2854-9
10946893
J Clin Endocrinol Metab. 2000 Jun;85(6):2160-6
10852446
Hypertension. 2001 Sep;38(3 Pt 2):688-91
11566957
Arq Bras Endocrinol Metabol. 2004 Oct;48(5):682-6
15761539
J Clin Endocrinol Metab. 2000 May;85(5):1863-7
10843166
J Hum Hypertens. 2001 Mar;15(3):173-6
11317201
Steroids. 1995 Jan;60(1):48-51
7792815
J Steroid Biochem Mol Biol. 2001 Sep;78(3):215-29
11595502
J Hum Hypertens. 2005 Apr;19(4):325-7
15660117
J Clin Endocrinol Metab. 1997 Nov;82(11):3570-3
9360508
J Pediatr. 2001 May;138(5):715-20
11343049
J Clin Endocrinol Metab. 1999 Dec;84(12):4341-4
10599685
Nature. 1992 Jan 16;355(6357):262-5
1731223
J Clin Endocrinol Metab. 2000 Sep;85(9):3313-8
10999827
Can Med Assoc J. 1966 Nov 26;95(22):1109-19
4288576
Clin Exp Pharmacol Physiol. 2001 Dec;28(12):1087-90
11903322
Biochem Biophys Res Commun. 1995 Feb 15;207(2):565-71
7864844